购物车
- 全部删除
- 您的购物车当前为空
GRKs-IN-1 hydrochloride has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50: 130 nM) and GRK5 (IC50: 7.1 μM).
GRKs-IN-1 hydrochloride has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50: 130 nM) and GRK5 (IC50: 7.1 μM).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,055 | 期货 | |
2 mg | ¥ 1,735 | 期货 | |
5 mg | ¥ 3,010 | 期货 | |
10 mg | ¥ 4,710 | 期货 | |
25 mg | ¥ 8,450 | 期货 | |
50 mg | ¥ 14,060 | 期货 | |
100 mg | ¥ 19,160 | 期货 | |
200 mg | 询价 | 期货 | |
500 mg | 询价 | 期货 | |
1 mL x 10 mM (in DMSO) | ¥ 3,235 | 期货 |
产品描述 | GRKs-IN-1 hydrochloride has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50: 130 nM) and GRK5 (IC50: 7.1 μM). |
靶点活性 | GRK2:30 nM, GRK5:7.1 μM |
体外活性 | GRKs-IN-1 hydrochloride (Compound 14as) is a derivative 14as of paroxetine, shows a 100-fold improvement in cardiomyocyte contractility assays over paroxetine. |
别名 | GRK2-IN-1 hydrochloride |
分子量 | 488.94 |
分子式 | C24H26ClFN4O4 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 250 mg/mL (511.31 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.